Drug Price Cap Bill Cripples State's Biopharma Industry

Retrieved on: 2021-05-20 02:48:45

Tags for this article:

Click the tags to see associated articles and topics

Drug Price Cap Bill Cripples State's Biopharma Industry. View article details on hiswai:

Excerpt

More than 20 biotech and biopharma companies and organizations, including Connecticut's Alexion, Boehringer Ingelheim, Sanofi, and Pfizer, are ...

Article found on: www.cbia.com